management in this specific population which often leads to suboptimal treatment of patients with gout and impaired renal function.[2] Objectives: This study aimed to evaluate the use of uric acid lowering therapies (ULT) and presence of undesirable clinical outcomes in patients with CKD stage 鈮 ...